Effects of a combination of cannabidiol and delta-9-tetrahydrocannabinol on key biological functions of HTR-8/SVneo extravillous trophoblast cells

Toxicology. 2023 Aug 15:495:153614. doi: 10.1016/j.tox.2023.153614. Epub 2023 Aug 9.

Abstract

In recent years, cannabis use has increased among pregnant women. In addition, the phytocannabinoids cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC) alone or in combination are being used for therapeutical applications. THC and CBD are able to cross the placenta and a lot remains unknown concerning their impact on angiogenesis and extravillous trophoblasts' (EVTs) migration and invasion, which are essential processes for placentation. Thus, in this study, the HTR-8/SVneo cell line was employed to evaluate the effects of CBD, THC and of their combination (1:1, 2 µM). Cannabinoids affected epithelial-mesenchymal transition, as showed by increased expression of the epithelial protein marker E-cadherin for CBD and CBD plus THC treatments, and decrease of mesenchymal intermediate filament vimentin for all treatments. The gene expression of the metalloproteinases MMP2 and MMP9, and of their inhibitors TIMP1 and TIMP2 was increased, except the latter for THC treatment. Moreover, CBD reduced cell migration and invasion, an effect that was enhanced by its combination with THC. CBD with or without THC also upregulated the gene expression of PGF, while the anti-angiogenic factor sFLT1 was increased for all treatments. VEGFA and FLT1 were not affected. Alone or combined CBD and THC also decreased tube segments' length. Additionally, ERK1/2 and STAT3 phosphorylation was increased in the CBD and CBD plus THC-treated cells, while THC only activated STAT3. AKT activation was only affected by CBD. This work demonstrates that the exposure to cannabinoid-based products containing CBD and/or THC, may interfere with key processes of EVTs differentiation. Therefore, crucial phases of placental development can be affected, compromising pregnancy success.

Keywords: Angiogenesis; Cannabidiol; Cell invasion; Delta-9-tetrahydrocannabinol; Epithelial-mesenchymal transition; Extravillous trophoblast cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cannabidiol* / toxicity
  • Cannabinoids*
  • Cannabis*
  • Dronabinol / toxicity
  • Female
  • Humans
  • Placenta
  • Pregnancy
  • Trophoblasts
  • Vascular Endothelial Growth Factor Receptor-1

Substances

  • Cannabidiol
  • Dronabinol
  • FLT1 protein, human
  • Vascular Endothelial Growth Factor Receptor-1
  • Cannabinoids